Nine months of rheumatoid arthritis suppression with one stem cell dose? – MedCity News
MedCity News |
Nine months of rheumatoid arthritis suppression with one stem cell dose?
MedCity News Rheumatoid arthritis (RA) patients given a single intravenous dose of Mesoblast's novel stem cell therapy were still demonstrating therapeutic benefits nine months later, according to new Phase 2 data from the Melbourne, Australia-based company. |
